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Summary
Objective: In recent years, studies have been initiated to disclose the proteome of human chondrocytes and cartilage. Despite these studies,
comprehensive information of the chondrocyte proteome remains limited. This study aimed to further explore the proteome expressed by
human knee chondrocytes, and to study the functional aspects of heat-shock protein 27 (HSP27), a protein related to the previously described
aBcrystallin, in chondrocyte biology.
Methods: Chondrocytes isolated from human knee articular cartilage were cultured in a three-dimensional alginate culture system. To simplify
the protein mixtures, proteins extracted from chondrocyte cell lysates were fractionated based on hydrophobicity and molecular weight. Pro-
teins were digested and the resulting peptides were separated and identiﬁed by an on-line two-dimensional (2-D) nanoliquid chromatography
(nanoLC)-system coupled to a quadrupole time-of-ﬂight (Qq-TOF) mass spectrometer. Differential expression analysis of HSP27 was per-
formed by Western Blotting and quantitative polymerase chain reaction (QPCR). The effects of HSP27 on chondrocyte biology were explored
by suppression of HSP27 expression induced by RNA interference (RNAi).
Results: In this study, we identiﬁed proteins with unknown functions together with membrane proteins, transcription factors and other low
abundant proteins, which have not yet been described in chondrocytes. Based on previous knowledge on the related protein aBcrystallin,
we selected HSP27 from the chondrocyte proteome database. Differential expression analysis revealed a decreased expression of HSP27
in Osteoarthritic (OA) chondrocytes. RNAi experiments revealed that HSP27 is involved in interleukin-1b (IL-1b) induced IL-6 secretion.
Conclusion: These ﬁndings highlight that small HSPs, especially HSP27, play a prominent role in the maintenance of human articular
chondrocyte homeostasis.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritic (OA) has become one of the major health
problems in the western world1. The key hallmark of this
disease is a slow progressive degeneration of the articular
cartilage2. Articular cartilage forms a specialized, smooth
connective tissue that is weight bearing and that serves
as a gliding surface allowing a lithe movement of the joints.
Cartilage is a very attractive tissue as it contains only one
single cell type. However, for proteomics studies this is
a very challenging tissue, as this sole cell type comprises
only 1% of the cartilage volume and the majority of the tis-
sue is formed by highly abundant extracellular-matrix
(ECM) components3. As it is generally accepted thataDD and DE equally contributed to this work
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440disturbances in chondrocyte metabolism are involved in
the pathogenesis of OA4, the knowledge of the chondro-
cyte- as well as the cartilage-proteome may provide new in-
sights, which may assist in the elucidation of pathways
involved in cartilage destruction associated with OA.
In recent years, several attempts have been undertaken to
tackle the human chondrocyte and/or cartilage proteomes.
An extensive prefractionation method followed by two-di-
mensional (2-D)E gel separation was proposed by Vincourt
et al.5. A limited number of unique proteins were identiﬁed
by matrix assisted laser desorption ionziation (MALDI)-TOF
mass spectrometry of gel-separated spots. A 1-D SDS-
PAGE approach combined with tandem mass spectrometry,
resulted in the identiﬁcation of 100 different proteins from
knee cartilage specimens6. A 2-DE based approach was
used to identify proteins of monolayer cultured human articu-
lar chondrocytes by Ruiz-Romero et al.7, yielding a set of 93
unique proteins. In a subsequent study, the same group initi-
ated the proteome characterization of the mitochondria of
chondrocytes, resulting in the identiﬁcation of 49 unique pro-
teins8. Rollin et al. used a gel-based approach to identify 30
differentially expressed proteins in OA-chondrocytes9. Re-
cently, a ﬁrst large-scale proteome analysis of human
441Osteoarthritis and Cartilage Vol. 18, No. 3cartilage tissue has been performed10. Despite these stud-
ies, our knowledge about the proteome of cartilage tissue
as well as isolated chondrocytes, can still be improved.
More speciﬁc, the ‘hidden’ proteome which is not accessible
by standard 2-DE methods, is poorly characterized.
Prefractionation based on hydrophobicity is a well-known
sample preparation method in 2-D gel applications to
achieve more simpliﬁed spot patterns11. Whereas 2-DE re-
mains very attractive for differential expression analysis12,
2-D liquid chromatography (LC) methods, the so-called shot-
gun proteomics approaches, have become the method of
choice for the large-scale characterization of a given pro-
teome. In this study, we combine such 2-D LC MS-approach
with prefractionation methods to explore the proteome of
human chondrocytes. Linking this knowledge with known
mediators of chondrocyte biology, allowed us to identify
heat-shock protein 27 (HSP27) as a novel identiﬁedmediator
of chondrocyte metabolism.Materials and methodsISOLATION AND CULTURE OF CHONDROCYTESArticular knee cartilage from donors without arthropathy (four male, two
female) was obtained within 24 h post-mortem. All donors had died as a result
of trauma or a brief illness and none of them had been receiving corticoste-
roids or cytostatic drugs. OA-affected cartilage was obtained from 27 patients
(13 male, 14 female) within 24 h from total knee arthroplasty. The study pro-
tocol was approved by the local Ethics Committee. The cartilage was diced
into small fragments and chondrocytes were isolated by sequential enzy-
matic digestion (hyaluronidase, pronase, collagenase (Sigma-Aldrich, Stein-
heim, Germany)) as described in detail elsewhere13. Trypan blue exclusion
revealed that >95% of the cells were viable after isolation.
Chondrocyte cultures in alginate beads were prepared and maintained as
described previously14. For each sample15e17, 5 106 chondrocytes were
lysed and treated as described below.SAMPLE PREPARATION FOR NANOLC-MSTotal cell lysate
Isolated chondrocytes from two different patient samples, were resus-
pended and lysed in a denaturing buffer containing 8 M urea. After reduction
and alkylation, proteins were digested with sequencing grade trypsin at 37C
for 12e16 h. Peptide solutions were desalted using solid-phase extraction
cartridges (Oasis, Waters, Milford, USA), dried in a vacuum-centrifuge
and frozen at 80C until use.
Fractionation based on hydrophobicity and Mw
Isolated chondrocytes from two additional patient samples, were
resuspended in Reagent 1 (40 mM Tris) from the ReadyPrep Sequential
Extraction Kit (Bio-Rad, Hercules, CA, USA), containing protease
inhibitors (Roche Diagnostics, Mannheim, Germany) and a phosphatase
inhibitor-cocktail (Sigma-Aldrich, Steinheim, Germany). Cells were lysed by
sonication and the proteins were extracted using the ReadyPrep Sequential
Extraction Kit (Bio-Rad) according to the manufacturer’s protocol. This
resulted in a soluble, an intermediate and a hydrophobic protein fraction11.
All fractions were dialysed using 2 kDaMw cut-off centrifugal devices (Viva-
spin, Vivascience). The resulting concentrates were diluted in dissolution
buffer (Applied Biosystems) supplemented with a SDS-containing denaturant
solution. After reduction and alkylation, the intermediate and hydrophobic
fractions were digested using sequencing grade trypsin. The soluble fraction
was further fractionated, based on molecular weight using 300 kDa,
100 kDa, 10 kDa and 2 kDaMw cut-off centrifugal devices (Vivaspin, Vivas-
cience). Each resulting concentrate was digested as described above. For
a second chondrocyte sample, the resulting pellet after the second extrac-
tion, was resuspended in a 2% SDS-solution containing 5% b-mercaptoetha-
nol. The suspension was heated at 95C for 5 min. The sample was cooled
to room temperature and centrifuged at 15,000 rpm. The resulting superna-
tant was subjected to 1-D gelelectrophoresis. Precision Plus All Blue stan-
dards (Bio-Rad) were run in parallel as molecular weight markers. The gel
was stained with Colloidal Coomassie blue (Pierce). The lane was divided
in eight zones and each zone was isolated and cut in smaller fragments
followed by in-gel digestion as described previously14, except that larger
volumes were used.ON-LINE 2-D NANOLC-MSPeptides were resuspended in buffer A (Buffer A: 2.5 mM NaH2PO4, 3%
acetonitrile (ACN), pH¼ 2.7). For electrospray ionization (ESI) quadrupole
time-of-ﬂight (Qq-TOF) analysis the resuspended peptides were injected
on an Ultimate 3000 autosampler (LC Packings, Sunnyvale, CA, USA) and
trapped on a Poros 10S strong-cation exchange (SCX) column (300 mm
i.d. 15 cm). Peptides were eluted from the SCX column by a 840 min dis-
continuous gradient from 0 to 100% buffer B (Buffer B: 2.5 mM NaH2PO4,
500 mM NaCl, 3% ACN, pH¼ 2.7, ﬂow rate¼ 6 ml/min). Two reversed-phase
trap-columns (PepMap, LC Packings) were used for parallel trapping of the
peptides, eluting from the SCX column, prior to the separation on a C18 Pep-
Map column (LC Packings) by a 70 min linear gradient from 6 to 100% buffer
C (80% ACN and 0.1% formic acid in water). A Switchos pump (LC Pack-
ings) [pumping 12 ml/min buffer D (0.1% formic acid in water)] was coupled
to the LC-system to wash the trap-columns prior to peptide elution. ESI
Qq-Tof analysis was performed on a Q-Tof Ultima mass spectrometer (Wa-
ters, Milford USA), which was coupled to the LC-system via a nanoLC inlet.
The instrument was calibrated using fragment ions generated from MS/MS of
Glu-ﬁbrinopeptide B (Sigma-Aldrich).DATABASE SEARCHINGTheQ-TOFwas operated in a data-dependent mode by performing MS/MS
scans for the 7 most intense peaks from each MS scan. The MS scan range
was 450e1100 m/z. Peak list ﬁles were generated from the raw data by Mas-
cot Distiller version 2.1.0.0 (Matrix Science). The generated ﬁles were merged
into a single.mgf ﬁle. Database searches against the Swiss-Prot database
(version 51.6) were performed using an in-house licensed Mascot search en-
gine (version 2.2.0.0) (www.matrixscience.com). The search parameters
were: a maximum of 1 missed cleavage using trypsin; ﬁxed modiﬁcations
were carbamidomethylation and variable modiﬁcations were oxidation of
methionine and N-terminal acetylation; the mass tolerances were set to 0.
20 and 0.15 Da for precursor ions and fragment ions respectively; one C13
was allowed. Only protein identiﬁcations with a P-value less than 0.01 were
accepted. Identities for individual spectra were automatically designated as
valid when a P-value below 0.01 was reached for the protein identiﬁcation.
Only spectra with a charge state þ2 and þ3 are accepted. All experimental
details (expect value, Mascot-score, sequence, etc) are listed in the
supplementary table. Individual peptides with a Mascot-score above 20 are
reported. Protein identiﬁcations based on a single peptide hit were manually
validated and only accepted if three consecutive y or b ions matched
intense peaks in the MS/MS-spectrum. To estimate the number of false
positives, the spectra were searched against a decoy database (reversed
sequences). The false discovery rate at the protein level was calculated as
follows: (number of proteins identiﬁed in reversed database)/(number of
proteins identiﬁed in SwissProtþ numbers of proteins identiﬁed in reversed
database). More details about the protein identiﬁcation algorithm can be
found in the Supplementary Table 1.WESTERN BLOT ANALYSISChondrocyte samples of six healthy donors (four male, two female, me-
dian age SD: 46.5 23.6 years) and six OA patients (three male, three fe-
male, median age SD: 66.5 11.1 years) were collected, isolated and
cultured as described above. Cell lysates of chondrocytes were prepared
by resuspending cell pellets in 40 mM Tris from the ReadyPrep Sequential
Extraction Kit (Bio-Rad, Hercules, CA, USA), containing protease inhibitors
(Roche Diagnostics, Mannheim, Germany) and a phosphatase inhibitor-
cocktail (Sigma-Aldrich, Steinheim, Germany). Cells were lysed by sonica-
tion and the soluble proteins were isolated by centrifugation. Equal amounts
(30 mg as determined by 2-D Quant kit, GE Healthcare, Fairﬁeld, USA) of sol-
uble fractions of 18 samples [6 NoNo (chondrocytes isolated from healthy
cartilage), six NoOA (chondrocytes isolated from visually intact cartilage of
OA-patients) and six OAOA (chondrocytes isolated from visually damaged
zones of OA-cartilage)] were loaded on 10% SDS-PAGE gels. Western Blot-
ting was performed as described earlier15. The antibody used was a mouse
monoclonal anti-HSP27 (G3.1) (Abcam, Cambridge, UK). The densitometric
analysis was performed by Quantity-One Software (Bio-Rad) and based on
two independent Western Blot experiments.REAL-TIME PCRChondrocytes from 11 additional patients (median age: 66 years 10.04
years) were isolated and cultured as described above. After the culture pe-
riod, Trizol (Invitrogen) was added to the isolated cells. RNA was extracted
and copy-DNA (cDNA) prepared as previously described15.
Real-time PCR was performed using the ABI 7000 Sequence Detection
System (Applied Biosystems). Each reaction utilized 5 ml of cDNA and a mix-
ture of 20 ml of iTaq Supermix with Rox (Bio-Rad, Hercules, CA), TaqMan
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in triplicate. The following TaqMan Gene Expression Assays were
used: COL2A1 Hs01064869_m1, interleukin-6 (IL-6) Hs00174131_m1,
COL1A1 Hs01076777_m1 and HSP27 Hs00356629_g1. The thermocycler
conditions were 2 min at 50C, followed by 2 min at 95C and 45 cycles,
each at 95C for 15 s and 60C for 1 min. Expression levels were normalized
to those of human glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
and peptidylprolyl isomerase A (PPIA). Relative quantization was calculated
using the 266Ct method16.CHONDROCYTE CULTURE WITH PRO-INFLAMMATORY
CYTOKINESChondrocytes were isolated from three additional patients and cultured as
described above for 7 days with IL-1b (R&D Systems, Abingdon, UK)
(0.1 ng/ml) or tumor necrosis factor-a (TNF-a) (R&D systems, Abingdon,
UK) (10 ng/ml). Each stimulation was performed in duplicate per patient. Af-
ter the culture period cells were isolated, proteins extracted, separated and
blotted as described above. For the messenger RNA (mRNA) analysis,
chondrocyte cultures from ﬁve patients were stimulated overnight with IL-
1b (0.5 ng/ml).MONOLAYER EXPANSIONPhenotypically stable chondrocytes isolated from three OA-patients were
seeded in monolayer culture at low density (20.000 cells/cm2). At different
time points Trizol (Invitrogen) was added to the isolated cells, and RNA
was extracted according to the manufacturer’s instructions, followed by
cDNA preparation as described above. Real-time PCR conditions were sim-
ilar as above. At the same time points proteins were extracted in Laemmli
buffer from parallel cultures, separated and electroblotted as described
above.RNA-INTERFERENCE (RNAI)Chondrocytes, isolated from visually intact cartilage of OA-patients, were
cultured in alginate as described above. After the culture period, cells were
isolated and seeded in monolayer culture at a density of 50,000 cells/cm2.
Cells were transfected with 5 nM siRNA (ﬁnal concentration) directed against
the HSP27 mRNA (Qiagen, Venlo, The Netherlands) or with a non-silencing
control (All Stars Negative control siRNA, Qiagen), using HiPerfect transfec-
tion reagent (Qiagen). Separate transfections using siRNA directed against
different sequences in the HSP27 mRNA strand have been performed.
The transcript sequences targeted by the different siRNA sequences were:
50- GCGCGTGTCCCTGGATGTCAA-30 and 50-AAGGACGAGCATGGCTA-
CATC-30. In case of IL-1b stimulation, media were replaced and cells were
stimulated with IL-1b (2 ng/ml), 48 h after transfection. After a 6 h stimulation
period, media were collected, cells were lysed and mRNA was isolated using
Trizol. Real-time PCR analysis was performed as above. IL-6 enzyme linked
immuno sorbent assay (ELISA) measurements were performed using the
Human IL-6 DuoSet (R&D Systems, Abingdon, UK).ResultsPREFRACTIONATION COMBINED WITH 2-D NANOLC TANDEM
MS YIELDS A ‘‘CHONDROCYTE PROTEOME DATABASE’’The aim of this study was to provide a database which
may assist on future research in articular chondrocytes. Us-
ing extensive prefractionation followed by ESI-MS/MS, 779
unique proteins expressed by cultured chondrocytes could
be reliably (P< 0.01) identiﬁed. The false discovery rate
was estimated at 0.3% by searching a reversed database.
At the protein level, this resulted in a false discovery rate
of 0.88%. The complete list of identiﬁcations and the corre-
sponding experimental data can be found in the Supple-
mentary Table.
The cellular localization of the identiﬁed proteins was as-
signed by searching the GeneOntology database, indicating
a diverse distribution of the identiﬁed proteins (see Supple-
mentary Figure 1b). 556 of the identiﬁed proteins are local-
ized in the cytoplasm, 203 proteins were annotated to the
membrane, 129 proteins to the nucleus and 73 are located
in the extracellular environment.RATIONAL TARGET SELECTION FROM THE DATABASE MAY
PROVIDE NOVEL POTENTIAL PROTEINS INVOLVED IN
OA-PATHOGENESISIn a previous report we identiﬁed aBcrystallin as a poten-
tial interesting protein in OA-pathogenesis15. aBcrystallin
belongs to the family of small sHSPs, a family of molecular
chaperones with similar structures and functionalities17. Un-
til now, 10 different sHSPs have been identiﬁed in human18.
In the present study, we identiﬁed three members of this
family: the previously described aBcrystallin (HSPb5),
HSP20 (HSPb6) and HSP27 (HSPb1). HSP27 and aBcrys-
tallin are the most frequently investigated sHSPs. Both are
very closely related, in function as well as in structure (re-
viewed in19). Based here on, we further examined the ex-
pression of HSP27 in OA-affected chondrocytes, revealing
a reduced abundance of this protein in cultured OA-chon-
drocytes (33% reduction, P< 0.05-ManneWhitney U-test)
[Fig. 1(A, B)]. In 5 of the 6 patients analyzed, HSP27 shows
a higher abundance in chondrocytes isolated from visually
intact, compared to visually damaged zones from the
same knee joint [Fig. 1(C)]. To evaluate whether the differ-
ential abundance is regulated at the gene expression level,
real-time PCR analyses were performed in 11 additional
paired samples. These data were consistent with the pro-
tein data, indicating a differential gene expression
[Fig. 1(D)]. It is generally known that pro-inﬂammatory cyto-
kines such as IL-1b and TNF-a may play an important role
in chondrocyte metabolism. To investigate if the expression
of HSP27 is regulated by these cytokines, articular chondro-
cytes were cultured in the presence of IL-1b (0.1 ng/ml) and
TNF-a (10 ng/ml) for 7 days. Western Blot analyses (Fig. 2,
upper panel) clearly show an IL-1b/TNF-a dependent down-
regulation of the HSP27 expression, indicating that a cyto-
kine-driven mechanism might be responsible for the differ-
ential expression of HSP27 in OA-chondrocytes.
Real-time PCR experiments (Fig. 2, lower panel) showed
that this differential abundance is directly regulated at the
transcription level: IL-1b stimulation resulted in
a 72.9 9.5% reduction (n¼ 5) of the HSP27 expression.MONOLAYER EXPANSION OF HUMAN ARTICULAR CHONDRO-
CYTES RESULTS IN A RAPID ACCUMULATION IN HSP27
PROTEIN LEVELSIt is generally known that expansion of articular chon-
drocytes in monolayer culture is associated with loss of
the chondrocyte phenotype20, 21. In this study, chondro-
cytes were seeded at low density (20,000 cells/cm2)
and allowed to expand till conﬂuency (after 5e6 days).
The expansion associated dedifferentiation is also re-
ﬂected in our experiments by a decreased expression
of collagen type II and increased expression of collagen
type I [Fig. 3(B)]. At three different time points (0 h,
48 h, at conﬂuency), cells were isolated and protein
levels were analyzed by Western Blot. A rapid accumula-
tion of HSP27 protein levels (factor 2.50 0.44 at 48 h)
was observed [Fig. 3(A)]. In contrast, quantitative poly-
merase chain reaction experiments showed stable levels
of HSP27 mRNA.HSP27 MEDIATES IL-1-INDUCED IL-6 SECRETIONA previous report showed involvement of HSP27 in inﬂam-
matory gene expression induced by IL-1b in HeLa cells, in
which HSP27 functions as a stabilizing factor of the IL-6
mRNA22. Therefore, we used RNAi to investigate the role of
Fig. 1. A: Expression of HSP27 in human articular chondrocytes isolated from healthy and OA cartilage. The protein levels of HSP27 in ex-
tracts of chondrocytes isolated from healthy cartilage (lanes 1e2 and 7e10) and from visually intact (lanes 3e4 and 11e14) and visually dam-
aged zones (lanes 5e6 and 15e18) of OA cartilage were determined by Western Blot analysis. B: Densitometric analysis of Western Blots
reveals a differential expression between the sample groups. Left panel: Results of the densitometric analysis, showing the mean expression
(S.E.M.) in each group (normalized to NoNo expression levels). P-values were calculated using ManneWhitney U-test for the comparison
between NoNo vs NoOA and NoNo vs OAOA. NoOA and OAOA samples were compared by Wilcoxon’s paired sample test. Black bars:
NoNo; white: NoOA; shaded: OAOA. C: Results of the densitometric analysis, showing the expression levels of HSP27 in chondrocytes iso-
lated from visually intact zones (NoOA) and visually damaged zones (OAOA) of the same knee joint from 6 different patients. D: Comparison
of HSP27 mRNA levels in chondrocytes isolated from 11 OA-patients. In 9 of 11 samples a reduction of HSP27 expression was observed.
mRNA levels have been calculated as the mean expression compared to two different household genes (GAPDH, PPIA).
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tion in human articular chondrocytes. Therefore, chondrocyte
cultures were transfected with two different siRNA sequences
directed against different loci at the HSP27 mRNA sequence.
Transfection of these sequences resulted in anefﬁcient reduc-
tion of HSP27 expression (si1: 34.3 22.4%; si6:
48.0 3.86%) [Fig. 4(A)]. After 48 h, cultures were stimulated
with IL-1b, resulting in an induction of IL-6 secretion, as mea-
sured by ELISA. The siHSP27 transfected cultures, showed
a statistically signiﬁcant lower (mean reduction, si1: 16.6%
(P> 0,1, Wilcoxon signed rank test), si6: 21.8%
(P¼ 0.0078), three patients, triplicate transfection per patient
and per condition) induction of IL-6 compared to controls
[Fig. 4(B-C)]. Similar trends were observed at the mRNA level(mean reduction, si1: 12.4 2.5%; si6: 12.2 11.2%, n¼ 3).
These ﬁndings indicate that HSP27 mediates, at least in part,
IL-6 secretion induced by IL-1b. In contrast, cell cultures trans-
fectedwith siRNAsequences against aBcrystallin, showed no
statistically signiﬁcant changes in IL-6 concentrations
[Fig. 4(C)]. Additional experiments showed further functional
discrepancies betweenHSP27 and aBcrystallin. In a previous
report we have shown that RNAi mediated suppression of the
smallHSPaBcrystallinwasassociatedwitha reducedexpres-
sion of collagen type II and aggrecan15. Similar experiments
were performed for HSP27. In contrast, these RNAi experi-
ments showed no reduction in expression of these genes en-
coding matrix proteins (COL2A1: 1.1%, Aggrecan: þ7.9%
compared to control transfections) (data not shown).
Fig. 2. IL-1b/TNF-a dependent expression of HSP27. Upper panel:
Representative Western Blot of cultured chondrocytes, stimulated
with TNF-a (10 ng/ml; Lane 1-2), IL-1b (0.1 ng/ml; Lane 3-4) and
unstimulated controls (Lane 5-6). Each stimulation was performed
in duplicate per patient sample. Lower panel: % reduction of
HSP27 expression by IL-1b (0.5 ng/ml) compared to non-stimulated
control samples. Data represent ﬁve individual patient samples.
Each dot represent an individual patient sample. mRNA levels
have been calculated as the mean expression (SD) compared
to two different household genes (GAPDH, PPIA).
Fig. 3. A: HSP27 protein levels accumulate quickly in chondrocytes
seeded in monolayer at low density. The ﬁgure shows a representa-
tive patient sample. Expression levels were determined by Western
Blot at different time points (0 h, 48 h, Conﬂuence). A time depen-
dent increase was observed at the protein level, which is associ-
ated with a loss of the chondrocyte phenotype. B: Average
(S.E.M.) mRNA (HSP27, Col2A1, COL1A1) and HSP27 protein
levels of at least three different patient samples in chondrocyte
monolayer cultures at different time points. Dedifferentiation during
expansion is illustrated by the decreasing expression of COL2A1
and increasing expression of COL1A1.
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The knowledge of the proteome of each individual human
tissue and cell type is one of the major goals of the Humane
Proteome Organisation (HUPO). Moreover, a more ex-
tended view on the chondrocyte’s proteome may assist in
the development of protein- as well as cDNA-arrays, which
cover novel identiﬁed genes expressed by chondrocytes.
Whereas, major initiatives have been undertaken to charac-
terize proteomes from serum, brain, liver, cardiovascular tis-
sue, etc., very little is known about the proteome of human
articular cartilage and chondrocytes. This manuscript aimed
to extend the current knowledge of the chondrocyte pro-
teome by using a combination of sample prefractionation
techniques to identify less abundant proteins.
As might be expected from chondrocytes cultured in algi-
nate beads, collagens type I, II and VI were identiﬁed next
to other well known matrix proteins, among these the aggre-
can core protein, biglycan, perlecan, the hyaluronan and
proteoglycan link protein and chondroitin sulphate proteo-
glycan four precursor. The three different a chains which
form the heterotrimer type VI collagen all could be identiﬁed
with high sequence coverage (a1: 35%, a2: 26%, a3: 25%)
indicating a relatively high abundance especially if com-
pared to collagen type II (1% sequence coverage). How-
ever, it is known that type VI collagen forms only a small
portion of the cartilage collagens23. This clearly indicates
that during cell isolation after alginate culture the chondro-
cytes are selectively isolated with their cell-associated ma-
trix from the interterritorial matrix, as the pericellular matrixis rich in type VI collagen and excludes type II collagen24.
It has to be noted that upon permission of hydroxylysine
and hydroxyproline modiﬁcations, a much higher sequence
coverage can be achieved for collagen type II, 13% (Mas-
cot-score: 698). However, this is still substantially lower
than the collagen type VI sequence coverage. As might
be expected, sequence coverage and mascot-scores are
much lower for collagen type I chains (Col1A1: 6%, 178;
Col1A2: 3%, 147).
Next to well-characterized proteins, we identiﬁed proteins
of unknown function. Further studies are warranted to in-
vestigate whether the expression of these proteins (e.g.,
C6orf115, C1orf123) is speciﬁc for chondrocytes or whether
these are also expressed in other tissues.
During our study we identiﬁed a member of the small
heat-shock family, HSP27. Our group previously reported
a role for another small HSP, aBcrystallin, in chondrocyte
metabolism15. Based on the identiﬁcation of HSP27 and
the functional and structural relationships with aBcrystallin,
we further performed differential expression analysis on
HSP27, both on the mRNA level and protein level, indicat-
ing a decreased expression in OA-affected chondrocytes.
Based on the observation that HSP27 expression is directly
regulated at the transcription level by the pro-inﬂammatory
cytokine IL-1b, one may suggest that the differential expres-
sion in OA is dictated by a cytokine-driven mechanism. Sim-
ilar observations were made for aBcrystallin, which may
indicate that these small HSPs may be important mediators
in IL-1b driven alterations in chondrocyte metabolism.
Whereas both, aBcrystallin and HSP27 show similar fea-
tures in terms of expression analysis, some functional dis-
crepancies were observed. In contrast to aBcrystallin,
Fig. 4. A: HSP27 mRNA levels are reduced after siRNA transfection with two different siRNA sequences (si1, si6). Values represent the mean
relative expression S.E.M. of three patient samples. B: IL-6 levels of IL-1 stimulated (si1-iL-1, si6-IL-1, siCtrl-IL-1) samples and a non-stim-
ulated sample (siCtrl) from a representative patient sample. Similar data were obtained in three independent experiments. C: Relative IL-6
levels are reduced in HSP27 knock-down samples (si1-IL-1, si6-IL-1) compared to controls (siCtrl-IL-1), in contrast to CRYAB knock-down
samples (siCRYAB-IL-1). Bars represent mean relative reduction of IL-6 levels S.E.M. Experiments were repeated in three individual patient
samples, with triplicate transfections per condition.
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with reduced expression levels of Collagen type II and ag-
grecan. However, the involvement of HSP27 in IL-1b in-
duced gene expression in human articular chondrocytes
was demonstrated, a relationship that was previously re-
ported in HeLa cells22. It is known that OA-chondrocytes
show a reduced responsiveness to IL-1b25. In this study
we demonstrated that HSP27 levels are reduced in
OA-chondrocytes and, in addition, that a decreased
HSP27 expression results in reduced responsiveness of
chondrocytes to IL-1b. Therefore, these data suggest that
reduced responsiveness of OA-chondrocytes to IL-1b may
be, in part, regulated by the reduced HSP27 expression.
In addition, it is clear that the IL-1b HSP27 relationship
may reﬂect a complex bidirectional mechanism as HSP27
itself regulates the IL-1b sensitivity of the chondrocyte. On
the other hand, we showed that IL-1b regulates the
HSP27 expression in articular chondrocytes.
In addition to involvement of HSP27 in inﬂammatory sig-
nalling, it has been shown that overexpression of HSP25
(the murine analogue of HSP27) in C1 cell lines, interferes
with chondrogenic differentiation of this cell line26. Based
here on, we investigated whether the expansion of chon-
drocytes in monolayer culture, known to induce dediffer-
entiation of the chondrocyte phenotype, is associated
with an altered expression of HSP27. Protein levels of
HSP27 show a rapid accumulation [Fig. 3(A)] upon expan-
sion. In contrast, mRNA levels remain stable over time, in-
dicating that other events such as decreased protein
degradation, alterations in protein translation, etc. may oc-
cur. We previously reported the differentiation status de-
pendent expression of aBcrystallin, which showed
a rapid decrease in expression upon chondrocyte expan-
sion. These data further conﬁrm the importance of the
small HSP family in chondrocyte homeostasis. The differ-
entiation status dependent expression of small HSPsmight be interesting in the context of characterized autol-
ogous chondrocyte transplantation procedures, wherein
the expression level of HSP27 and aBcrystallin might be
useful to indicate the differentiation status, and thereby
the ability to synthesize a functional ECM of an expanded
chondrocyte culture.
Altogether, these data combined with the earlier reported
aBcrystallin expression in OA-chondrocytes, clearly point to
a generalized distortion of the small HSP response in cul-
tured OA-chondrocytes. In most pathologic conditions
(e.g., cancers) an increased expression of small HSPs is
observed. For example, aBcrystallin has been reported as
an oncoprotein in breast cancer27. In contrast to overex-
pression of these proteins under stress conditions, it is
known that HSP27 and aBcrystallin may show a tissue spe-
ciﬁc distribution in the absence of stress in healthy condi-
tions, as is obviously true in articular chondrocytes. The
signiﬁcance of the constitutive expression of these Hsps
is probably linked to protection of the cells against stress
or to a speciﬁc function in this particular tissue19. Based
on our data, further research is warranted to elucidate the
role of this interesting protein family and to provide insights
in the mechanisms involved herein.
In conclusion, we disclosed a heat shock family member,
HSP27, as a novel regulator of human articular chondrocyte
homeostasis. HSP27 is closely related to aBcrystallin,
which both coordinately regulate cytokine levels by articular
chondrocytes. These ﬁndings underscore the role of small
HSPs in chondrocyte biology.Conﬂict of interest
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the differentiation status dependent expression of small
heat-shock proteins in chondrocytes.
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